Protozoan co-infections and parasite influence on the efficacy of vaccines against bacterial and viral pathogens

L Akoolo, SC Rocha, N Parveen - Frontiers in Microbiology, 2022 - frontiersin.org
A wide range of protozoan pathogens either transmitted by vectors (Plasmodium, Babesia,
Leishmania and Trypanosoma), by contaminated food or water (Entamoeba and Giardia), or …

Mouse Models for Mycobacterium tuberculosis Pathogenesis: Show and Do Not Tell

P Soldevilla, C Vilaplana, PJ Cardona - Pathogens, 2022 - mdpi.com
Science has been taking profit from animal models since the first translational experiments
back in ancient Greece. From there, and across all history, several remarkable findings have …

Examining the complex relationship between tuberculosis and other infectious diseases in children

E Whittaker, E López-Varela, C Broderick… - Frontiers in …, 2019 - frontiersin.org
Millions of children are exposed to tuberculosis (TB) each year, many of which become
infected with Mycobacterium tuberculosis. Most children can immunologically contain or …

Infection against infection: parasite antagonism against parasites, viruses and bacteria

SS Shen, XY Qu, WZ Zhang, J Li, ZY Lv - Infectious diseases of poverty, 2019 - Springer
Background Infectious diseases encompass a large spectrum of diseases that threaten
human health, and coinfection is of particular importance because pathogen species can …

PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled …

SC Murphy, GA Deye, BKL Sim, S Galbiati… - PLoS …, 2021 - journals.plos.org
PfSPZ-CVac combines 'PfSPZ Challenge', which consists of infectious Plasmodium
falciparum sporozoites (PfSPZ), with concurrent antimalarial chemoprophylaxis. In a …

A breath of fresh air: impact of insect-borne protozoan parasites on the respiratory system

S Araujo, D Mabille, AB Garcia, G Caljon - Trends in Parasitology, 2024 - cell.com
Abstract The protozoan parasites Plasmodium, Leishmania, and Trypanosoma are
transmitted by hematophagous insects and cause severe diseases in humans. These …

Micro-nanoemulsion and nanoparticle-assisted drug delivery against drug-resistant tuberculosis: Recent developments

SK Suman, N Chandrasekaran… - Clinical Microbiology …, 2023 - journals.asm.org
Tuberculosis (TB) is a major global health problem and the second most prevalent infectious
killer after COVID-19. It is caused by Mycobacterium tuberculosis (Mtb) and has become …

Type-II NADH Dehydrogenase (NDH-2): a promising therapeutic target for antitubercular and antibacterial drug discovery

S Sellamuthu, M Singh, A Kumar… - Expert opinion on …, 2017 - Taylor & Francis
Introduction: Tuberculosis (TB) is highly dangerous due to the development of resistance to
first-line drugs. Moreover, Mycobacterium tuberculosis (Mtb) has also developed resistance …

Interleukin-4 expression is increased in patients with tuberculosis: a systematic review and meta-analysis

J He, L Song, P Zheng - Medicine, 2023 - journals.lww.com
Background: Interleukin-4 (IL-4) is an important cytokine in the Th2 differentiation of CD4+ T
cells, which modulates immune responses and participates in host defense against …

Hepatitis C virus affects tuberculosis-specific T cells in HIV-negative patients

MA El-Mokhtar, SG Elgendy, AS Eldin, EA Hassan… - Viruses, 2020 - mdpi.com
The occurrence of tuberculosis (TB) and hepatitis C virus (HCV) infections in the same
patient presents a unique clinical challenge. The impact of HCV infection on the immune …